↓ Skip to main content

Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy

Overview of attention for article published in Molecular Neurodegeneration, October 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy
Published in
Molecular Neurodegeneration, October 2021
DOI 10.1186/s13024-021-00479-8
Pubmed ID
Authors

Silvia Bono, Marco Feligioni, Massimo Corbo

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 21%
Student > Master 4 10%
Professor > Associate Professor 2 5%
Researcher 2 5%
Student > Doctoral Student 1 3%
Other 3 8%
Unknown 19 49%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 23%
Neuroscience 5 13%
Chemistry 2 5%
Agricultural and Biological Sciences 1 3%
Medicine and Dentistry 1 3%
Other 1 3%
Unknown 20 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2021.
All research outputs
#13,392,948
of 23,310,485 outputs
Outputs from Molecular Neurodegeneration
#664
of 864 outputs
Outputs of similar age
#180,242
of 439,396 outputs
Outputs of similar age from Molecular Neurodegeneration
#17
of 20 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 864 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.4. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,396 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.